Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 72Lung Neoplasms 9Adenocarcinoma of Lung 7Brain Neoplasms 5Non-squamous Non-small Cell Lung Cancer 4NSCLC 4Adenocarcinoma 4Mesothelioma, Malignant 3Colorectal Neoplasms 3Nonsquamous Non-Small Cell Lung Cancer 2Non-squamous Cell Non-Small Cell Lung Cancer 2Neoplasms 2Meningeal Carcinomatosis 2Lymphoma 2Glioma 2Central Nervous System Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Untreated Advanced Non-Small Cell Lung Cancer 1Unresectable Stage III NSCLC 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thoracic Neoplasms 1Stomach Neoplasms 1Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1Staging IV NSCLC 1Squamous Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Respiratory Tract Neoplasms 1

Interventions

toripalimab 1Pemetrexed 1Paclitaxel 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × EGFR Positive Non-small Cell Lung Cancer × Pemetrexed × Clear all
NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
40 enrolled
Thoracic

EGFR Positive Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡